Paradiem, LLC Vertex Pharmaceuticals Inc Transaction History

Paradiem, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $2.17 Million - $2.56 Million	-11,570 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $805,928 - $939,419	3,893 Added 50.71%	11,570 $2.49 Million
Q4 2020 Jan 29, 2021	BUY	$207.01 - $276.09 $1.59 Million - $2.12 Million	7,677 New	7,677 $1.73 Million

1,624

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Paradiem, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradiem, LLC with notifications on news.